Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
Oysta Digital Platform and Dosage Manager
2025

Share:

Oysta Digital Platform and Dosage Manager

Medical Tech , Mobile health care

The Oysta digital platform combines two stand-alone solutions, Oysta Dosage Manager and Oysta Digital Service. It helps healthcare providers, patients, teachers, and guardians manage ADHD in children by offering medication adherence support, educational information, data analysis, and reporting. Research shows that ADHD medication adherence interventions positively impact adherence and treatment outcomes.

Client / Manufacturer

OnDosis

Gothenburg, SE

Tiefenbacher Group

Hamburg, DE
Design

Star

Wroclaw, PLAgnieszka Billewicz, Aili Larusson, Maciej Jasicki, Aleksandra Straczek, Tomasz Trefler, Ferdinado Valenti, Valery Loboda
Date of Launch
2025
Development Time
up to 24 Month
Target Regions
Europe, North America
Target Groups
Consumers / Users, Trade / Industry, "Guardians of children diagnosed with ADHD, Healthcare professionals, Teachers, Medical Technologies"

RELATED PROJECTS